Table 4.
Associations of main food sources of phytoestrogens and total and cause-specific mortality
| Tofu | ||||||
| <1 serving/month |
<1 serving/week |
≥1 serving/week |
Ptrend |
|||
| Total mortality | 1 | 0.93 (0.90, 0.95) | 0.85 (0.80, 0.89) | <0.0001 | ||
| CVD mortality | 1 | 0.92 (0.87, 0.96) | 0.86 (0.77, 0.96) | 0.001 | ||
| Cancer mortality | 1 | 0.92 (0.88, 0.97) | 0.98 (0.89, 1.07) | 0.42 | ||
| Other mortality | 1 | 0.93 (0.90, 0.97) | 0.78 (0.73, 0.84) | <0.0001 | ||
|
Soy milk | ||||||
|
<1 serving/month |
<1 serving/week |
≥1 serving/week |
Ptrend |
|||
| Total mortality | 1 | 0.73 (0.67, 0.80) | 0.84 (0.79, 0.89) | <0.0001 | ||
| CVD mortality | 1 | 0.97 (0.81, 1.15) | 0.89 (0.78, 1.01) | 0.06 | ||
| Cancer mortality | 1 | 0.75 (0.62, 0.90) | 0.91 (0.80, 1.26) | 0.09 | ||
| Other mortality | 1 | 0.89 (0.79, 1.00) | 0.89 (0.82, 0.97) | 0.005 | ||
|
Whole grains | ||||||
|
Q1 (Low) |
Q2 |
Q3 |
Q4 |
Q5 (High) |
Ptrend |
|
| Total mortality | 1 | 0.93 (0.91, 0.96) | 0.90 (0.87, 0.92) | 0.86 (0.83, 0.88) | 0.81 (0.78, 0.83) | <0.0001 |
| CVD mortality | 1 | 0.86 (0.81, 0.91) | 0.85 (0.80, 0.89) | 0.79 (0.75, 0.83) | 0.76 (0.72, 0.81) | <0.0001 |
| Cancer mortality | 1 | 0.93 (0.88, 0.98) | 0.88 (0.84, 0.93) | 0.84 (0.80, 0.89) | 0.79 (0.75, 0.84) | <0.0001 |
| Other mortality | 1 | 0.97 (0.93, 1.01) | 0.94 (0.90, 0.98) | 0.91 (0.87, 0.95) | 0.85 (0.81, 0.89) | <0.0001 |
|
Tea | ||||||
|
<1 cup/week |
<1 cup/d |
>1 cup/d |
Ptrend |
|||
| Total mortality | 1 | 0.95 (0.93, 0.97) | 0.94 (0.91, 0.96) | <0.0001 | ||
| CVD mortality | 1 | 0.97 (0.94, 1.01) | 0.93 (0.88, 0.98) | 0.01 | ||
| Cancer mortality | 1 | 0.93 (0.90, 0.97) | 0.94 (0.89, 0.98) | 0.01 | ||
| Other mortality | 1 | 0.96 (0.93, 0.99) | 0.95 (0.91, 0.98) | 0.005 | ||
|
Flaxseed1 | ||||||
|
No consumption |
Consumption |
|||||
| Total mortality | 1 | 0.89 (0.83, 0.96) | ||||
| CVD mortality | 1 | 1.05 (0.90, 1.23) | ||||
| Cancer mortality | 1 | 0.85 (0.73, 1.00) | ||||
| Other mortality | 1 | 0.94 (0.86, 1.04) | ||||
|
Flaxseed oil1 | ||||||
|
No consumption |
Consumption |
|||||
| Total mortality | 1 | 0.91 (0.84, 0.99) | ||||
| CVD mortality | 1 | 0.99 (0.83, 1.18) | ||||
| Cancer mortality | 1 | 1.03 (0.86, 1.23) | ||||
| Other mortality | 1 | 0.92 (0.83, 1.02) | ||||
Data were combined from Nurses’ Health Study and Health Professionals Follow-Up Study. Estimates were calculated in Cox proportional-hazards models and adjusted for age, ethnicity (Caucasians/other races), smoking status (never, former, current [1–14, 15–24, or ≥25 cigarettes/d], or missing), alcohol intake (0, 0.1–4.9, 5.0–14.9, and ≥15.0 g/d for females; 0, 0.1–4.9, 5.0–29.9, and ≥30.0 g/d for males; or missing), physical activity (metabolic equivalents of task-hour/week), multivitamin use (yes/no), aspirin use (yes/no), history of hypertension (yes/no) and hypercholesterolemia (yes/no), family history of myocardial infarction (yes/no), family history of cancer (yes/no), family history of diabetes (yes/no), menopausal status and postmenopausal hormone use (premenopause, postmenopause [never, former, or current hormone use], or missing; for females), body mass index (<23, 23–24.9, 25–29.9, 30–34.9, >35 kg/m2, or missing), and total energy intake (kcal/d), and modified alternative health eating index score. Ptrend < 0.05 was considered statistically significant.
The analysis involving flaxseed products only included data after 2006 when they were specifically assessed.